CCND2 rearrangements are the most frequent genetic events in cyclin D1(-) mantle cell lymphoma (Q36628297)

15 August 2017

CCND2 rearrangements are the most frequent genetic events in cyclin D1(-) mantle cell lymphoma (English)

1 reference

Leticia Quintanilla-Martinez

15 August 2017

1 reference

13

Iwona Wlodarska

0 references

19

Leticia Quintanilla-Martinez

0 references

Sílvia Beà

24

Sílvia Beà

1 reference

15 August 2017

Guillem Clot

4

0 references

Alba Navarro

Alba Navarro

5

0 references

Itziar Salaverria

Itziar Salaverria

1

0 references

Elaine Jaffe

Elaine S Jaffe

21

0 references

Elías Campo

Elias Campo

23

0 references

Reiner Siebert

22

Reiner Siebert

1 reference

15 August 2017

17

Andreas Rosenwald

1 reference

15 August 2017

9

Grzegorz Rymkiewicz

1 reference

15 August 2017

8

Renata Woroniecka

1 reference

15 August 2017

11

Elena M Hartmann

1 reference

15 August 2017

10

Wolfram Klapper

1 reference

15 August 2017

Armando López-Guillermo

18

Armando Lopez-Guillermo

1 reference

15 August 2017

Cristina Royo

2

1 reference

15 August 2017

Alejandra Carvajal-Cuenca

3

1 reference

15 August 2017

Alejandra Valera

6

1 reference

15 August 2017

Joo Y Song

7

1 reference

15 August 2017

Pierre Sujobert

12

1 reference

15 August 2017

Judith A Ferry

14

1 reference

15 August 2017

Philippe Gaulard

15

1 reference

15 August 2017

German Ott

16

1 reference

15 August 2017

Nancy L Harris

20

1 reference

15 August 2017

language of work or name

English

0 references

publication date

18 December 2012

1 reference

15 August 2017

1 reference

15 August 2017

121

1 reference

15 August 2017

1394-1402

1 reference

15 August 2017

8

1 reference

Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics

15 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3578954

Non-nodal type of mantle cell lymphoma is a specific biological and clinical subgroup of the disease

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3578954

In situ mantle cell lymphoma: clinical implications of an incidental finding with indolent clinical behavior

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3578954

The complex landscape of genetic alterations in mantle cell lymphoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3578954

Addition of rituximab to chemotherapy alone as first-line therapy improves overall survival in elderly patients with mantle cell lymphoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3578954

Analysis of the coding genome of diffuse large B-cell lymphoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3578954

Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3578954

Pathway discovery in mantle cell lymphoma by integrated analysis of high-resolution gene expression and copy number profiling

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3578954

mir-17-92, a cluster of miRNAs in the midst of the cancer network

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3578954

Waved aCGH: to smooth or not to smooth.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3578954

Characterization of D-cyclin proteins in hematolymphoid neoplasms: lack of specificity of cyclin-D2 and D3 expression in lymphoma subtypes

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3578954

Strong lymphoid nuclear expression of SOX11 transcription factor defines lymphoblastic neoplasms, mantle cell lymphoma and Burkitt's lymphoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3578954

SOX11 expression is highly specific for mantle cell lymphoma and identifies the cyclin D1-negative subtype.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3578954

MicroRNA expression, chromosomal alterations, and immunoglobulin variable heavy chain hypermutations in Mantle cell lymphomas.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3578954

Differential diagnosis of cyclin D2+ mantle cell lymphoma based on fluorescence in situ hybridization and quantitative real-time-PCR.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3578954

Different molecular mechanisms causing 9p21 deletions in acute lymphoblastic leukemia of childhood.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3578954

Uniparental disomies, homozygous deletions, amplifications, and target genes in mantle cell lymphoma revealed by integrative high-resolution whole-genome profiling.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3578954

Nuclear expression of the non B-cell lineage Sox11 transcription factor identifies mantle cell lymphoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3578954

Genetic and molecular pathogenesis of mantle cell lymphoma: perspectives for new targeted therapeutics

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3578954

Specific secondary genetic alterations in mantle cell lymphoma provide prognostic information independent of the gene expression-based proliferation signature

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3578954

Cyclin D1-negative mantle cell lymphoma: a clinicopathologic study based on gene expression profiling

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3578954

Recurrent genetic aberrations in thymoma and thymic carcinoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3578954

Translocations targeting CCND2, CCND3, and MYCN do occur in t(11;14)-negative mantle cell lymphomas.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3578954

A microRNA cluster as a target of genomic amplification in malignant lymphoma.

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3578954

Increased number of chromosomal imbalances and high-level DNA amplifications in mantle cell lymphoma are associated with blastoid variants.

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3578954

CD5-positive, cyclinD1-negative mantle cell lymphoma with a translocation involving the CCND2 gene and the IGL locus

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3578954

SOX11 is useful in differentiating cyclin D1-positive diffuse large B-cell lymphoma from mantle cell lymphoma

21 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3578954

Genomic and Gene Expression Profiling Defines Indolent Forms of Mantle Cell Lymphoma

4 December 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3578954

Cyclin D1-negative mantle cell lymphoma with cryptic t(12;14)(p13;q32) and cyclin D2 overexpression

4 December 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3578954

Cyclin D1-negative blastoid mantle cell lymphoma identified by SOX11 expression

4 December 2018

1 reference

12 December 2020

Cyclin D3 is a target gene of t(6;14)(p21.1;q32.3) of mature B-cell malignancies

1 reference

12 December 2020

Significance of cyclin D1 overexpression for the diagnosis of mantle cell lymphoma: a clinicopathologic comparison of cyclin D1-positive MCL and cyclin D1-negative MCL-like B-cell lymphoma

1 reference

12 December 2020

A chromosomal translocation in cyclin D1-negative/cyclin D2-positive mantle cell lymphoma fuses the CCND2 gene to the IGK locus

1 reference

12 December 2020

10.1182/BLOOD-2012-08-452284

Identifiers

DOI

1 reference

15 August 2017

1 reference

15 August 2017

1 reference